Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)
South Korea · Delayed Price · Currency is KRW 235,000
+14,000 (6.33%)
Oct 31, 2025, 1:40 PM KST
Sam Chun Dang Pharm. Market Cap
Sam Chun Dang Pharm. has a market cap or net worth of 5.14 trillion as of October 30, 2025. Its market cap has increased by 58.31% in one year.
Market Cap
5.14T
Enterprise Value
5.17T
Revenue
215.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
235,000.00
Market Cap Chart
Since September 11, 2001, Sam Chun Dang Pharm.'s market cap has increased from 3.32B to 5.14T, an increase of 154,716.36%. That is a compound annual growth rate of 35.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 5.14T | 48.82% |
| Dec 30, 2024 | 3.45T | 96.33% |
| Dec 28, 2023 | 1.76T | 82.00% |
| Dec 29, 2022 | 966.58B | 1.04% |
| Dec 30, 2021 | 956.65B | -47.20% |
| Dec 30, 2020 | 1.81T | 137.75% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 87.69T |
| Celltrion | 39.50T |
| ALTEOGEN | 25.46T |
| SK Biopharmaceuticals | 9.08T |
| Yuhan | 8.94T |
| Peptron | 6.37T |
| HLB Co., Ltd. | 6.25T |
| PharmaResearch | 5.57T |